111 related articles for article (PubMed ID: 36746098)
1. High surgical volume is associated with improved survival in head and neck cancer.
Rygalski CJ; Huttinger ZM; Zhao S; Brock G; VanKoevering K; Old MO; Teknos TN; Rocco JW; Puram SV; Seim NB; Swendseid B; Haring CT; Eskander A; Kang SY
Oral Oncol; 2023 Mar; 138():106333. PubMed ID: 36746098
[TBL] [Abstract][Full Text] [Related]
2. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
3. Academic Affiliation and Surgical Volume Predict Survival in Head and Neck Cancer Patients Receiving Surgery.
Farquhar DR; Masood MM; Lenze NR; Sheth S; Patel SN; Lumley C; Zanation AM; Weissler MC; Olshan AF; Hackman TG
Laryngoscope; 2021 Feb; 131(2):E479-E488. PubMed ID: 32449832
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma.
Torabi SJ; Benchetrit L; Kuo Yu P; Cheraghlou S; Savoca EL; Tate JP; Judson BL
JAMA Otolaryngol Head Neck Surg; 2019 Aug; 145(8):708-715. PubMed ID: 31194229
[TBL] [Abstract][Full Text] [Related]
5. Measuring Institutional Quality in Head and Neck Surgery Using Hospital-Level Data: Negative Margin Rates and Neck Dissection Yield.
Schoppy DW; Rhoads KF; Ma Y; Chen MM; Nussenbaum B; Orosco RK; Rosenthal EL; Divi V
JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1111-1116. PubMed ID: 28983555
[TBL] [Abstract][Full Text] [Related]
6. Explaining Racial Disparities in Surgically Treated Head and Neck Cancer.
Jassal JS; Cramer JD
Laryngoscope; 2021 May; 131(5):1053-1059. PubMed ID: 33107610
[TBL] [Abstract][Full Text] [Related]
7. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Facility Type and Volume on Outcomes in Head and Neck Mucosal Melanoma.
Roman KM; Torabi SJ; Bitner BF; Goshtasbi K; Haidar YM; Tjoa T; Kuan EC
Otolaryngol Head Neck Surg; 2023 May; 168(5):1079-1088. PubMed ID: 36939581
[TBL] [Abstract][Full Text] [Related]
9. Association of Type of Treatment Facility With Overall Survival After a Diagnosis of Head and Neck Cancer.
Carey RM; Fathy R; Shah RR; Rajasekaran K; Cannady SB; Newman JG; Ibrahim SA; Brant JA
JAMA Netw Open; 2020 Jan; 3(1):e1919697. PubMed ID: 31977060
[TBL] [Abstract][Full Text] [Related]
10. Case volume regionalization and volume-based outcome differences in cutaneous head and neck melanoma.
Roman KM; Torabi SJ; Goshtasbi K; Kuan EC; Tjoa T; Haidar YM
Head Neck; 2022 Nov; 44(11):2428-2436. PubMed ID: 35903986
[TBL] [Abstract][Full Text] [Related]
11. Volume-outcome relationships for head and neck cancer surgery in a universal health care system.
Eskander A; Irish J; Groome PA; Freeman J; Gullane P; Gilbert R; Hall SF; Urbach DR; Goldstein DP
Laryngoscope; 2014 Sep; 124(9):2081-8. PubMed ID: 24706437
[TBL] [Abstract][Full Text] [Related]
12. Association of Facility Volume With Positive Margin Rate in the Surgical Treatment of Head and Neck Cancer.
Nocon CC; Ajmani GS; Bhayani MK
JAMA Otolaryngol Head Neck Surg; 2018 Dec; 144(12):1090-1097. PubMed ID: 30347018
[TBL] [Abstract][Full Text] [Related]
13. Hospital volume and 5-year survival in head and neck cancer patients in Osaka, Japan.
Koyama S; Tabuchi T; Okawa S; Taniyama Y; Nakata K; Morishima T; Miyashiro I
Jpn J Clin Oncol; 2021 Oct; 51(10):1515-1522. PubMed ID: 34392346
[TBL] [Abstract][Full Text] [Related]
14. Risk of Disease Recurrence and Mortality Varies by Type of Fat Consumed before Cancer Treatment in a Longitudinal Cohort of Head and Neck Squamous Cell Carcinoma Patients.
Taha HM; Rozek LS; Chen X; Li Z; Zarins KR; Slade AN; Wolf GT; Arthur AE
J Nutr; 2022 May; 152(5):1298-1305. PubMed ID: 35170737
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
Lee NCJ; Kelly JR; An Y; Park HS; Judson BL; Burtness BA; Husain ZA
Cancer; 2019 Jun; 125(12):2018-2026. PubMed ID: 30748002
[TBL] [Abstract][Full Text] [Related]
16. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
Bollig CA; Zitsch RP
Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
[TBL] [Abstract][Full Text] [Related]
17. Distance Traveled to Head and Neck Cancer Provider: A Measure of Socioeconomic Status and Access.
Massa ST; Liebendorfer AP; Zevallos JP; Mazul AL
Otolaryngol Head Neck Surg; 2020 Feb; 162(2):193-203. PubMed ID: 31794337
[TBL] [Abstract][Full Text] [Related]
18. Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.
Barzi A; Lara PN; Tsao-Wei D; Yang D; Gill IS; Daneshmand S; Klein EA; Pinski JK; Penson DF; Quinn DI; Sadeghi S
Cancer; 2019 Nov; 125(21):3853-3863. PubMed ID: 31398279
[TBL] [Abstract][Full Text] [Related]
19. Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium.
Leroy R; Silversmit G; Stordeur S; De Gendt C; Verleye L; Schillemans V; Savoye I; Van Eycken L; Deron P; Hamoir M; Vermorken J; Grégoire V; Nuyts S
Eur J Cancer; 2020 May; 130():81-91. PubMed ID: 32179449
[TBL] [Abstract][Full Text] [Related]
20. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma.
Sineshaw HM; Ellis MA; Yabroff KR; Han X; Jemal A; Day TA; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):247-255. PubMed ID: 31944232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
